Clinical & Experimental Immunology

Early indicators of immunodeficiency in adults and children: protocols for screening for primary immunological defects
pp. 201-203(3)
Authors: Sewell, W. A. C.; Khan, S.; Doré, P. C.

Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists
pp. 204-214(11)
Author: de Vries, E.

Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients
pp. 215-218(4)
Authors: Veltkamp, M.; Grutters, J. C.; van Moorsel, C. H. M.; Ruven, H. J. T.; van den Bosch, J. M. M.

Immunoglobulins and complement factor C4 in adult rhinosinusitis
pp. 219-227(9)
Authors: Seppänen, M.; Suvilehto, J.; Lokki, M.-L.; Notkola, I.-L.; Järvinen, A.; Jarva, H.; Seppälä, I.; Tahkokallio, O.; Malmberg, H.; Meri, S.; Valtonen, V.

Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia
pp. 228-234(7)
Authors: Perez-Castellano, M.; Peñaranda, M.; Payeras, A.; Milà, J.; Riera, M.; Vidal, J.; Pujalte, F.; Pareja, A.; Villalonga, C.; Matamoros, N.

CD134 expression on CD4⁺ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus
pp. 235-242(8)
Authors: Patschan, S.; Dolff, S.; Kribben, A.; Dürig, J.; Patschan, D.; Wilde, B.; Specker, C.; Philipp, T.; Witzke, O.

Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients
pp. 243-251(9)
Authors: Hübner, M. P.; Manfras, B. J.; Margos, M. C.; Eiffler, D.; Hoffmann, W. H.; Schulz-Key, H.; Kern, P.; Soboslay, P. T.

Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3^dimCD56⁺ natural killer T cells in fast treatment responders
pp. 252-260(9)
Authors: Veenstra, H.; Baumann, R.; Carroll, N. M.; Lukey, P. T.; Kidd, M.; Beyers, N.; Bolliger, C. T.; van Helden, P. D.; Walzl, G.

Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes
pp. 261-270(10)
Authors: Mäkelä, M.; Öling, V.; Marttila, J.; Waris, M.; Knip, M.; Simell, O.; Ilonen, J.

Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality
pp. 271-276(6)
Authors: Stebbing, J.; Bower, M.; Mandalia, S.; Nelson, M.; Gazzard, B.

Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults
pp. 277-286(10)
Authors: Baril, L.; Dietemann, J.; Essevaz-Roulet, M.; Béniguel, L.; Coan, P.; Briles, D. E.; Guy, B.; Cozon, G.

Anti-oxidant enzyme activities and expression and oxidative damage in patients with non-immediate reactions to drugs
pp. 287-295(9)
Authors: Cornejo-Garcia, J. A.; Mayorga, C.; Torres, M. J.; Fernandez, T. D.; R-Pena, R.; Bravo, I.; Mates, J. M.; Blanca, M.

Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state
pp. 296-301(6)
Authors: Guerreiro, J. B.; Santos, S. B.; Morgan, D. J.; Porto, A. F.; Muniz, A. L.; Ho, J. L.; Teixeira, A. L.; Teixeira, M. M.; Carvalho, E. M.

Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent
pp. 302-307(6)
Authors: Muhlebach, M. S.; MacDonald, S. L.; Button, B.; Hubbard, J. J.; Turner, M. L.; Boucher, R. C.; Kilpatrick, D. C.

Anti-C1q antibodies in hepatitis C virus infection
pp. 308-312(5)
Authors: Saadoun, D.; Sadallah, S.; Trendelenburg, M.; Limal, N.; Sene, D.; Piette, J. C.; Schifferli, JA; Cacoub, P.

Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents
pp. 313-321(9)
Authors: Kaur, G.; Tirkey, N.; Bharrhan, S.; Chanana, V.; Rishi, P.; Chopra, K.

Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells
pp. 322-331(10)
Authors: Chen, L.; Peterson, J. D.; Zheng, W.-Y.; Lin, S.-X.; Chan, L. S.

Perforin-independent rejection of transplanted human stem cells
pp. 332-338(7)
Authors: Kaiser, S.; Kägi, D.; Ihorst, G.; Kapp, U.

Arthritogenicity of collagen type II is increased by chlorination
pp. 339-345(7)
Authors: Westman, E.; Lundberg, K.; Erlandsson Harris, H.

Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products
pp. 346-356(11)
Authors: Chowdhury, P.; Sacks, S. H.; Sheerin, N. S.

Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts
pp. 357-364(8)
Authors: Lieke, T.; Steeg, C.; Graefe, S. E. B.; Fleischer, B.; Jacobs, T.

Major histocompatibility complex class I expression in human tonsillar and laryngeal epithelium
pp. 365-371(7)
Authors: Hobbs, C. G. L.; Rees, L. E. N.; Heyderman, R. S.; Birchall, M. A.; Bailey, M.

Epitopes of the class I major histocompatibility complex (MHC-I) recognized in the syngeneic or allogeneic context predominantly linked to antigenic peptide loading to its binding groove
pp. 372-379(8)
Authors: Nguyen van Binh, P.; Duc, H. T.

Phagocytic efficacy of macrophage-like cells as a function of cell cycle and Fcγ receptors (FcγR) and complement receptor (CR)3 expression
pp. 380-387(8)
Authors: Luo, Y.; Cook, E.; Fries, B. C.; Casadevall, A.

Corrigendum
pp. 388-388(1)

Corrigendum
pp. 388-388(1)